EUVIMEDEUVIMED entdecken
Crossref

Machine Learning-Driven Extracellular Vesicles Peptidomics Powers Precision Classification of Endometrial Cancer

Yunhan Yang, Dandan Li iD, Pengfei Wu, Haonan Yang, Jia Yi, Dan Zhao, Jiawei Yu, Ji Ji iD, Xiaojun Chen, Liang Qiao iD

Analytical Chemistry · 2025

DOI: 10.1021/acs.analchem.5c02234 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical Chemistry, 2025. Verfasst von Yunhan Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, and Minhang Hospital, Fudan University, Shanghai 200433, China. Hauptthemen laut MEDLINE: Extracellular Vesicles, Machine Learning, Endometrial Neoplasms, Peptides. Die Arbeit nennt 44 Literaturangaben. Gefördert von: Fudan University, National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endometrial cancer (EC) molecular subtyping is critical for prognosis and treatment but remains hindered by reliance on invasive tissue biopsies and time-consuming genomic sequencing. Here, we present a minimally invasive approach integrating MALDI-TOF mass spectrometry and LC-MS/MS-based peptidomic profiling of plasma extracellular vesicles (EVs) with machine learning for rapid EC screening and subtyping. EVs were isolated from EC patients and controls, and their peptidome fingerprints were analyzed. A machine learning model utilizing 12 discriminative MALDI-TOF MS features, the levels of CA125 and HE4, and clinical features related to cancer risk achieved an AUC of 0.867 in distinguishing EC from the controls. For molecular subtyping (POLE mutant, NSMP, MMRd, P53-abnormal), a multiclassification model demonstrated micro/macro-averaged AUCs of 0.91/0.90. LC-MS/MS identified 7,479 peptides, with fibrinogen α chain (FGA), protease serine 3 (PRSS3), and apolipoprotein A-I (APOA1) emerging as key biomarkers linked to specific subtypes. This study establishes a high-throughput, cost-effective platform for EC management, bridging translational gaps in precision oncology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesMachine LearningEndometrial NeoplasmsPeptidesProteomicsHumansFemaleBiomarkers, TumorTandem Mass SpectrometryChromatography, LiquidSpectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

Substanzen

PeptidesBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Chemistry, and Minhang Hospital, Fudan University, Shanghai 200433, China.
  • Obstetrics and Gynecology Hospital of Fudan University, Shanghai 200090, China.
  • Chemical Engineering Institute, Qingdao University of Science and Technology, Qingdao 266061, China.
  • Shanghai Tenth People's Hospital of Tongji University, Shanghai 200072, China.

ORCID-Profile: Dandan Li, Ji Ji, Liang Qiao

Förderung

  • Fudan University
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Yang, Y., Li, D., Wu, P., Yang, H., Yi, J., Zhao, D., Yu, J., Ji, J., Chen, X., & Qiao, L. (2025). Machine Learning-Driven Extracellular Vesicles Peptidomics Powers Precision Classification of Endometrial Cancer. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.5c02234

Vancouver

Yang Y, Li D, Wu P, Yang H, Yi J, Zhao D, et al. Machine Learning-Driven Extracellular Vesicles Peptidomics Powers Precision Classification of Endometrial Cancer. Analytical Chemistry. 2025. doi:10.1021/acs.analchem.5c02234

BibTeX
@article{Yang2025,
  author = {Yang, Yunhan and Li, Dandan and Wu, Pengfei and Yang, Haonan and Yi, Jia and Zhao, Dan and Yu, Jiawei and Ji, Ji and Chen, Xiaojun and Qiao, Liang},
  title = {Machine Learning-Driven Extracellular Vesicles Peptidomics Powers Precision Classification of Endometrial Cancer},
  journal = {Analytical Chemistry},
  year = {2025},
  doi = {10.1021/acs.analchem.5c02234}
}
Kostenlos starten →